Studies in non-small cell lung cancer have shown distinct biologic behavior and prognosis in KRAS/LKB1-, KRAS/TP53- or KRAS/p16-mutated tumors [28]. The gene discussed is TP53; the disease is non-small cell lung carcinoma.